RhumbLine Advisers
KRMD icon

RhumbLine Advisers’s KORU Medical Systems KRMD Stock Holding History

RhumbLine Advisers’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
29,131
+2,045
+8% +$8.38K ﹤0.01% 3460
2026
Q1 		$117K Sell
27,086
-2,494
-8% -$12.4K ﹤0.01% 3341
2025
Q4 		$172K Sell
29,580
-8,065
-21% -$38.6K ﹤0.01% 3245
2025
Q3 		$144K Sell
37,645
-882
-2% -$3.37K ﹤0.01% 3379
2025
Q2 		$138K Buy
+38,527
New +$109K ﹤0.01% 3419
2024
Q3 		– Sell
-3,186
Closed -$8.44K – 4267
2024
Q2 		$8.44K Sell
3,186
-28,059
-90% -$64.2K ﹤0.01% 4006
2024
Q1 		$73.7K Buy
31,245
+1,043
+3% +$2.24K ﹤0.01% 3533
2023
Q4 		$74.1K Hold
30,202
– – ﹤0.01% 3542
2023
Q3 		$81.5K Buy
30,202
+1,921
+7% +$5.26K ﹤0.01% 3523
2023
Q2 		$97.6K Buy
+28,281
New +$111K ﹤0.01% 3529
2021
Q2 		– Sell
-23,016
Closed -$81K – 3054
2021
Q1 		$81K Buy
23,016
+100
+0.4% +$433 ﹤0.01% 2955
2020
Q4 		$138K Buy
22,916
+1,980
+9% +$11.1K ﹤0.01% 2917
2020
Q3 		$151K Sell
20,936
-1,538
-7% -$13.6K ﹤0.01% 2770
2020
Q2 		$202K Buy
+22,474
New +$227K ﹤0.01% 2768

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RhumbLine Advisers's KRMD Position: Q2 2026 in Review

RhumbLine Advisers increased its KORU Medical Systems (KRMD) stake by 7.6% in Q2 2026, buying an estimated $8.38K and bringing the position to 29,131 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

RhumbLine Advisers first reported a position in KRMD in Q2 2020 and has held it in 14 quarters since. The position peaked at $202K in Q2 2020. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • RhumbLine Advisers held 29,131 shares of KORU Medical Systems worth $122K as of Q2 2026.
  • RhumbLine Advisers bought 2,045 KORU Medical Systems shares in Q2 2026, an estimated $8.38K.
  • KORU Medical Systems made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3460 holding.
  • RhumbLine Advisers first reported a position in KORU Medical Systems in Q2 2020 and has held it in 14 quarters since.
  • RhumbLine Advisers's KORU Medical Systems position peaked at $202K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.